Nuveen Asset Management
CHRS icon

Nuveen Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Nuveen Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		$131K Hold
95,056
– – ﹤0.01% 3269
2024
Q3 		$98.9K Hold
95,056
– – ﹤0.01% 3310
2024
Q2 		$164K Hold
95,056
– – ﹤0.01% 3252
2024
Q1 		$227K Sell
95,056
-666,263
-88% -$1.59M ﹤0.01% 3159
2023
Q4 		$2.54M Sell
761,319
-219,406
-22% -$731K ﹤0.01% 2302
2023
Q3 		$3.67M Buy
980,725
+700,899
+250% +$2.62M ﹤0.01% 2020
2023
Q2 		$1.19M Buy
279,826
+104,167
+59% +$445K ﹤0.01% 2575
2023
Q1 		$1.2M Sell
175,659
-286,867
-62% -$1.96M ﹤0.01% 2543
2022
Q4 		$3.66M Sell
462,526
-266,911
-37% -$2.11M ﹤0.01% 2090
2022
Q3 		$7.01M Sell
729,437
-158,148
-18% -$1.52M ﹤0.01% 1697
2022
Q2 		$6.43M Sell
887,585
-142,021
-14% -$1.03M ﹤0.01% 1783
2022
Q1 		$12.5M Buy
1,029,606
+323,408
+46% +$3.93M ﹤0.01% 1501
2021
Q4 		$11.3M Sell
706,198
-17,745
-2% -$283K ﹤0.01% 1617
2021
Q3 		$11.6M Sell
723,943
-36,788
-5% -$591K ﹤0.01% 1674
2021
Q2 		$10.5M Buy
760,731
+83,940
+12% +$1.16M ﹤0.01% 1835
2021
Q1 		$9.89M Buy
676,791
+15,985
+2% +$234K ﹤0.01% 1808
2020
Q4 		$11.5M Sell
660,806
-479,065
-42% -$8.33M ﹤0.01% 1619
2020
Q3 		$20.9M Sell
1,139,871
-3,004
-0.3% -$55.1K 0.01% 1032
2020
Q2 		$20.4M Sell
1,142,875
-100,961
-8% -$1.8M 0.01% 1036
2020
Q1 		$20.2M Sell
1,243,836
-697,864
-36% -$11.3M 0.01% 897
2019
Q4 		$35M Buy
1,941,700
+111,785
+6% +$2.01M 0.01% 862
2019
Q3 		$37.1M Buy
1,829,915
+667,224
+57% +$13.5M 0.02% 811
2019
Q2 		$25.7M Buy
+1,162,691
New +$25.7M 0.01% 1024